Grant RadarWorldwide funding
Log inGet started
Back to Grants
Health Open for ApplicationsRFA-HL-26-018

Catalyze: Product Definition for Small Molecules, Biologics, and Combination Products - Preliminary Product/Lead Series Identification and Combination Product Prototype (R33 - Clinical Trial Not Allow

National Institutes of Health opportunity RFA-HL-26-018

Eligible Applicants
Organization Types
UniversitiesNGOsSMEsGovernment Agencies
Eligible Countries / Regions
United States
Keywords
National Institutes of HealthRFA-HL-26-018Grants.gov
Related Grants
Health● Open
Environmental influences on Child Health Outcomes (ECHO) Cohort Data and Biospecimen Access (X01 Clinical Trial Not Allowed)
Varies
01 Mar 2028(516d)
HealthUpcoming
Infrastructure for Population Dynamics Research Program (iPOP)
Varies
HealthUpcoming
Ryan White HIV/AIDS Program Part B States/Territories Supplemental Grant Program
Varies
HealthUpcoming
Limited Competition for the Continuation of the National Consortium on Alcohol and Neurodevelopment in Adolescence (NCANDA) Data Analysis Resource (U24 Clinical Trials Optional)
Varies
Funding Amount
Varies
USD
Application Deadline
23 December 2027
447 days remaining
Opens: 22 Nov 2024
Apply Now
Programme Details
Programme Code
RFA-HL-26-018